← Back to Clinical Trials
Recruiting NCT05693701
Multicomponent Intervention Study- Blood Donors With High Cholesterol
Trial Parameters
Condition Lipid Metabolism Disorder
Sponsor University of Texas Southwestern Medical Center
Study Type INTERVENTIONAL
Phase N/A
Enrollment 100
Sex ALL
Min Age 18 Years
Max Age 75 Years
Start Date 2023-02-27
Completion 2027-04-30
Interventions
Implementation Strategy BundleUsual care notification
Brief Summary
The purpose and objective of this study is to improve cholesterol treatment among blood donors with FH (Familial Hypercholesterolemia).
Eligibility Criteria
Inclusion Criteria: * Blood donors from Carter BloodCare with high cholesterol meeting MEDPED FH criteria * Age 18 to 75 years Exclusion Criteria: * Currently taking medication to lower cholesterol * Taking any medication that can interact with statins * Pregnancy * Identified secondary cause of elevated lipids * Chronic liver disease or significantly elevated liver function tests (\> 3 times upper limit)